Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
Only eight women out of one hundred diagnosed with ovarian epithelial cancers, which progressed to the clinical stage IV, survive 10 years. First line therapies: surgery, chemotherapy, and radiation therapy in...
Clinical and Translational Medicine 2016 5:44
Published on: 30 November 2016